Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Mepyramine maleate manufacturers

6 products found

Filters

6 products found
The only dossier on the platform

mepyramine maleate

Nasal spray 1.5 mg, 2.5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal
Manufacturer #20828

​Established in 1989, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 31 countries and regions. With a dedicated team of over 1,500 employees, it operates GMP-certified facilities in Poland, producing a diverse range of products including tablets, capsules, creams, balms, external liquids, and powder sachets. As a GMP manufacturer, it holds certifications such as cGMP and ISO 9001:2000, ensuring adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

 

Manufacturer usually replies in 10 days

mepyramine maleate + dexpanthenol + lidocaine hydrochloride

Gel 1.5 % + 5 % + 1.5 % - 30 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #7170
A pharmaceutical manufacturer based in Europe that has been active in 20+ countries selling its products in Europe, CIS, Middle East, Africa, and LATAM for 60+ years. The main therapeutic areas include cardiology, CNS, and rare diseases. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

mepyramine maleate + lidocaine + dexpanthenol

Cutaneous gel 15 mg + 15 mg + 50 mg - 30 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #1430
This pharmaceutical company has over 20 years of experience serving domestic and international markets in diverse regions like the EU and North America. They specialize in manufacturing a wide range of pharmaceutical products, including prescription medications, likely encompassing key therapy areas such as nephrology, cardiology, oncology, and pediatrics. Their product portfolio includes various dosage forms and boasts GMP certifications. They actively engage in research and development, evidenced by mentions of new drug launches like "Urapidil" for hypertension and "Bivalirudin" used in COVID-19 patients with ECMO. While they do not engage in online sales, the company emphasizes its commitment to quality and high-tech production facilities.

Manufacturer usually replies in 19 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible